secwatch / observer
8-K/A filed January 7, 2026, 6:59 PM ET ticker CNTA CIK 0001847903
leadership confidence high sentiment neutral materiality 0.50

Centessa appoints Mario Accardi CEO effective Jan 1, 2026; base salary $600K, target bonus 50%

Centessa Pharmaceuticals plc

Centessa Pharmaceuticals plc filing history →

Source: SEC EDGAR
accession 0001193125-26-004896
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.